Aggression is a complex behavior dependent on numerous factors such as personal experiences, upbringing, social context, personality and genetics. Florian Reichmann and his team at the Med Uni Graz ...

NHS patients in England with cystic fibrosis will be among the first in Europe to access a new treatment for their condition, ...

A group of researchers at the VIB‑UGent Center for Medical Biotechnology has developed a new platform to isolate and analyze ...

Results Identification of a transmembrane CXC chemokine To identify new proteins of immunological interest, we conducted a two-step search of public domain human expressed sequence tag (EST ...

Center for Drug Evaluation (CDE) has granted approval to the investigational new drug (IND) application of InnoCare Pharma to ...

Alyftrek (vanzacaftor–tezacaftor–deutivacaftor), made by Vertex, represents the latest advance in CFTR modulator treatments that are transforming cystic fibrosis care by targeting the underlying cause ...

InnoCare receives China NMPA approval to conduct clinical trial of a novel B7-H3 targeted ADC ICP-B794: Beijing Monday, July 7, 2025, 15:00 Hrs [IST] InnoCare Pharma, a leading bi ...

Vertex Pharmaceuticals has announced a reimbursement agreement with NHS England for its cystic fibrosis (CF) medicine, ...

Quantitative measurements of intra-Golgi transport kinetics of diverse secretory cargos challenge the classic cisternal progression model and support the stable compartment model of the Golgi.

InnoCare Pharma gets China NMPA approval to conduct clinical trial for a novel ADC ICP-B794 in China: Beijing Saturday, July 5, 2025, 11:00 Hrs [IST] InnoCare Pharma, a commercial ...

Using artificial intelligence, researchers show how γ-secretase recognizes substrates – an important advance for fundamental ...

Researchers have discovered a highly conserved post translational modification in the STING pathway that when inhibited stops ...